1. Home
  2. SNGX vs YGMZ Comparison

SNGX vs YGMZ Comparison

Compare SNGX & YGMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • YGMZ
  • Stock Information
  • Founded
  • SNGX 1987
  • YGMZ 2002
  • Country
  • SNGX United States
  • YGMZ China
  • Employees
  • SNGX N/A
  • YGMZ N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • YGMZ Transportation Services
  • Sector
  • SNGX Health Care
  • YGMZ Consumer Discretionary
  • Exchange
  • SNGX Nasdaq
  • YGMZ Nasdaq
  • Market Cap
  • SNGX 7.4M
  • YGMZ 7.0M
  • IPO Year
  • SNGX 1987
  • YGMZ 2020
  • Fundamental
  • Price
  • SNGX $2.32
  • YGMZ $0.71
  • Analyst Decision
  • SNGX
  • YGMZ
  • Analyst Count
  • SNGX 0
  • YGMZ 0
  • Target Price
  • SNGX N/A
  • YGMZ N/A
  • AVG Volume (30 Days)
  • SNGX 621.8K
  • YGMZ 58.2K
  • Earning Date
  • SNGX 03-14-2025
  • YGMZ 01-01-0001
  • Dividend Yield
  • SNGX N/A
  • YGMZ N/A
  • EPS Growth
  • SNGX N/A
  • YGMZ N/A
  • EPS
  • SNGX N/A
  • YGMZ N/A
  • Revenue
  • SNGX $364,183.00
  • YGMZ $55,805,416.00
  • Revenue This Year
  • SNGX N/A
  • YGMZ N/A
  • Revenue Next Year
  • SNGX $76.64
  • YGMZ N/A
  • P/E Ratio
  • SNGX N/A
  • YGMZ N/A
  • Revenue Growth
  • SNGX N/A
  • YGMZ N/A
  • 52 Week Low
  • SNGX $1.83
  • YGMZ $0.64
  • 52 Week High
  • SNGX $14.88
  • YGMZ $6.24
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 36.12
  • YGMZ 36.53
  • Support Level
  • SNGX $2.23
  • YGMZ $0.64
  • Resistance Level
  • SNGX $2.39
  • YGMZ $0.75
  • Average True Range (ATR)
  • SNGX 0.17
  • YGMZ 0.08
  • MACD
  • SNGX 0.01
  • YGMZ -0.00
  • Stochastic Oscillator
  • SNGX 22.12
  • YGMZ 20.16

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About YGMZ MingZhu Logistics Holdings Limited

MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. Its segments are the trucking business, car owner services business, and liquor distribution business. It generates the majority of its revenue from the trucking segment.

Share on Social Networks: